Cannabis firm raises stg£25m
GW Pharmaceuticals, which is developing the world's first cannabis-based medicine for pain relief, has raised stg£25m through an initial public offering.
Chief executive Geoffrey Guy will see his paper fortune valued at stg£47m when the company floats on the junior AIM stock market next Thursday.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





